The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancerClaudia von Arx, Lucia Del Mastro, Pietro De Placido et al.|Cancer Treatment Reviews|2022Cited by 115
DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative reviewAnnarita Peddio, Alberto Servetto, Giovannella Palmieri et al.|Critical Reviews in Oncology/Hematology|2024Cited by 25
Insight on the Role of Leptin: A Bridge from Obesity to Breast CancerRoberto Buonaiuto, Carmine De Angelis, Fabiana Napolitano et al.|Biomolecules|2022Cited by 23
Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic InterventionRoberto Buonaiuto, Carmine De Angelis, Giuseppe Neola et al.|Biomolecules|2023Cited by 14
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational studyPietro De Placido, Grazia Arpino, Erica Pietroluongo et al.|Frontiers in Oncology|2022Cited by 11